AI
One other thing -- seems to me that a hadge fund strategy or somebody out there flipped a switch to short every EPS negative biotech stock under a dollar a share last week. From the git-go on Monday, there was a pretty aggressive bid assault this past week all over the place... several stocks I watch were under pressure.... Look for a weak week ahead and recovery after that... if "they" are able to cover... or... even better... with ORXE, the trade is so thin, maybe nobody will panic sell to these bastards and make them cover a lot higher...........
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
